Pharmaceutical drug products - to obtain source or sources of currently marketed drugs products for FDA research studies.
Ended Awarded
- Contract number
- 75F40125F19011
- Awardee
-
We Pharma, Inc. UEI EWAMVJSFNK29
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $300,000
Award facts
- Contract value 100% obligated
- $300,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Two Step
- Pricing
- Firm Fixed Price
- Place of performance
- Takoma Park, MD 20901, USA
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration (FDA) awarded a delivery order valued at $300,000 to We Pharma, Inc., doing business as WEP Clinical, for the provision of pharmaceutical drug products to support FDA research studies. The contract, which is firm fixed price with no set-aside designation, carries an ultimate completion date of September 16, 2026, and will be performed at the FDA's Takoma Park, Maryland location. We Pharma, a self-certified small disadvantaged business and limited liability company based in Morrisville, North Carolina, has established itself as a dedicated supplier of pharmaceutical products to the FDA through multiple contract awards.
This delivery order is issued under one of two significant Indefinite Delivery Contracts that We Pharma holds with the FDA, representing the company's sustained capability to provide currently marketed drug products and emergency delivery services for FDA regulatory science programs, including support to the Office of Pharmaceutical Quality Research. The contractor's demonstrated experience supplying pharmaceutical products across FDA offices nationwide, combined with its requirement to maintain updated pharmaceutical pricing lists and emergency delivery capabilities, positions it to fulfill the agency's research and regulatory pharmaceutical sourcing needs through the contract period.
Quick answers
Who was awarded contract 75F40125F19011?
75F40125F19011 was awarded to We Pharma, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 16, 2025.
How much is contract 75F40125F19011 worth?
The government has obligated $300,000 on 75F40125F19011.
Is contract 75F40125F19011 an order under another contract?
Yes. 75F40125F19011 is a delivery order under 75F40120D00032, an indefinite delivery contract.
Was contract 75F40125F19011 competed?
The extent of competition for 75F40125F19011 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award